X

Trial Profile

Phase I Study of Valproic Acid Given in Combination With Bevacizumab in Patients With Advanced Cancer to Determine Safety and Tolerability.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bevacizumab (Primary) ; Valproic acid
Indications Cancer
Focus Adverse reactions

Most Recent Events

30 Nov 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
16 Nov 2013 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center
02 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com